ArticleTranslational oncology2017

A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation.

Lily Mahapatra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.